Study Summary:
Medex Healthcare Research, Inc. is conducting a clinical trial for subjects with asthma (reversible airway constriction).
Qualified Participants Must:
Be 18 to 65 years of age
Be taking a stable dose of fluticasone (alone or in combination with other medicines) of at least 440 micrograms a day
Not have another underlying lung disorder (e.g. COPD, emphysema, or lung cancer)
Qualified Participants May Receive:
Study-related care, study doctor visits, and study-medication at no cost. Qualified participants may also receive payment for their travel.